General Announcement::Proposed Placement of 1,349,434 New Ordinary Shares to Anson Properties & Directors - Receipt of LQN

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
IX BIOPHARMA LTD. W260718 - SGXN57296778 - HQXW
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
30-Apr-2026 18:30:38
Status
New
Announcement Sub Title
Proposed Placement of 1,349,434 New Ordinary Shares to Anson Properties & Directors - Receipt of LQN
Announcement Reference
SG260430OTHRQH1V
Submitted By (Co./ Ind. Name)
Gwendolin Lee Soo Fern
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)

Please see attached.

Attachments

LQN Announcement 300426.pdf
Total size =156K